| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/22/2010 | EP2264173A2 Use of a double-stranded ribonucleic acid for targeted inhibition of the expression of a given target gene |
| 12/22/2010 | EP2264172A1 Oligomeric compounds for the modulation of HIF-1alpha expression |
| 12/22/2010 | EP2264152A2 Fusion constructs and use of same to produce antibodies with increased FC receptor binding affinity and effector function |
| 12/22/2010 | EP2264151A2 Fusion constructs and use of same to produce antibodies with increased FC receptor binding affinity and effector function |
| 12/22/2010 | EP2264072A1 Enhancement of antibody-mediated cytotoxicity. |
| 12/22/2010 | EP2264069A2 Purification of fibrinogen |
| 12/22/2010 | EP2264066A2 Novel insulin derivatives |
| 12/22/2010 | EP2264065A2 Novel Insulin Derivatives |
| 12/22/2010 | EP2264064A1 Modified exendins and exendin agonists |
| 12/22/2010 | EP2264063A1 Sclerostin binding antibody |
| 12/22/2010 | EP2264062A1 Beta sheet inhibiting peptides for preventing and/or treating alzheimer's disease |
| 12/22/2010 | EP2264061A1 Compositions and methods for inhibiting viral adhesion |
| 12/22/2010 | EP2264060A1 Compositions and methods for inhibiting viral adhesion |
| 12/22/2010 | EP2264059A1 Polypeptides, cDNAs encoding the same and utilization thereof |
| 12/22/2010 | EP2264057A1 Recombinant antigen |
| 12/22/2010 | EP2264052A2 Activatable recombinant neurotoxins |
| 12/22/2010 | EP2264050A2 Chimeric infectious DNA clones of porcine circovirus and uses thereof |
| 12/22/2010 | EP2264049A2 1-Desamino-8-d-arginyl vasopressin analogs |
| 12/22/2010 | EP2264047A1 High purity lipopeptides, lipopeptide micelles and processes for preparing same |
| 12/22/2010 | EP2263698A1 Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction |
| 12/22/2010 | EP2263694A1 Antitumor agent comprising the histone deacetylase inhibitor FK228 and a topoisomerase II inhibitor |
| 12/22/2010 | EP2263693A1 Combination therapies for B-cell lymphomas comprising administration of anti-CD20 antibody |
| 12/22/2010 | EP2263690A2 Chimeric infectious DNA clones of porcine circovirus and uses thereof |
| 12/22/2010 | EP2263689A2 Chimeric infectious DNA clones of porcine circovirus and uses thereof |
| 12/22/2010 | EP2263686A1 Pharmaceutical compositions comprising immunologically active herpes simplex virus (HSV) protein fragments |
| 12/22/2010 | EP2263685A2 Alkaline phosphatase for reducing immunological stress |
| 12/22/2010 | EP2263684A1 IL-21 derivatives |
| 12/22/2010 | EP2263683A1 Agent for treating skin aging and scars |
| 12/22/2010 | EP2263682A1 Use of polypeptides of the cupredoxin family in cancer therapy |
| 12/22/2010 | EP2263679A2 RNAi probes targeting cancer-related proteins |
| 12/22/2010 | EP2263678A2 Cladribine regimen for treating Multiple Sclerosis |
| 12/22/2010 | EP2263654A1 Compositions and methods to improve the oral absorption of antimicrobial agents |
| 12/22/2010 | EP2263652A1 Aerosols comprising nanoparticle drugs |
| 12/22/2010 | EP2263649A1 Pharmacological adjuvants based on coordination compounds of d-metals |
| 12/22/2010 | EP2263453A1 Transgenic animal model of neurodegenerative disorders |
| 12/22/2010 | EP2262829A1 A new type of consensus interferon and preparation method thereof |
| 12/22/2010 | EP2262825A2 Process to produce fibrillar proteins and method of treating using fibrillar proteins |
| 12/22/2010 | EP2262527A2 Method for achieving desired glial growth factor 2 plasma levels |
| 12/22/2010 | EP2262526A1 Stable amyloid beta monomers and oligomers |
| 12/22/2010 | EP2262525A1 Apoaequorin-containing compositions and methods of using same |
| 12/22/2010 | EP2262524A2 Compositions and methods for treating pathologic angiogenesis and vascular permeability |
| 12/22/2010 | EP2262523A1 Improved anticancer treatments |
| 12/22/2010 | EP2262522A1 Improved antitumoral treatments |
| 12/22/2010 | EP2262521A1 Ophthalmic compositions comprising a dipeptide |
| 12/22/2010 | EP2262520A2 Methods for prevention and treatment of acute renal injury |
| 12/22/2010 | EP2262519A2 Treatment of hearing and balance impairments with redox-active therapeutics |
| 12/22/2010 | EP2262474A2 Methods and compositions for wound healing |
| 12/22/2010 | EP2054440B1 Peptide derived from vascular endothelial growth factor receptor-1 binding integrin alpha5beta1, having proangiogenic activity |
| 12/22/2010 | EP1848456B1 Poly-epitope peptide derived from thymidylate synthase having immunological and anti-tumour activity |
| 12/22/2010 | EP1802270B1 Dermatological and/or cosmetic composition containing polypeptides |
| 12/22/2010 | EP1626983B8 Novel poly (ethylene glycol) modified erythropoietin agonists and uses thereof |
| 12/22/2010 | EP1610822B1 Liquid or freeze-dried pharmaceutical formulations of fsh and/or lh together with the non-ionic surfactant poloxamer 188 and a bacteriostatic agent |
| 12/22/2010 | EP1596879B1 Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis |
| 12/22/2010 | EP1419171B1 Methods for the synthesis of a modified hemoglobin solution |
| 12/22/2010 | EP1290182B1 Sphingosine kinase and uses thereof |
| 12/22/2010 | EP1135496B1 Ucp5 |
| 12/22/2010 | EP1019077B2 Novel exendin agonist compounds |
| 12/22/2010 | CN1481390B Immunomodulatory peptides derived from heat shock proteins and uses thereof |
| 12/22/2010 | CN101925364A 14-3-3 antagonists for prevention and treatment of arthritis |
| 12/22/2010 | CN101925362A Treatment and prevention of cardiac conditions using two or more isoforms of hepatocyte growth factor |
| 12/22/2010 | CN101921820A Preparation method of recombinant tumor specificity antiapoptotic factors with activity and application of products thereof |
| 12/22/2010 | CN101921788A Meretrix lysozyme gene and coding protein and application thereof |
| 12/22/2010 | CN101921741A Relative protein for resisting against prawn white spot syndrome viruses (WSSV), characteristic sequence and application thereof |
| 12/22/2010 | CN101921732A A virus causing respiratory tract illness in susceptible mammals |
| 12/22/2010 | CN101921330A Recombinant human interferon alpha 1b mutant and preparation method thereof |
| 12/22/2010 | CN101921329A Alpha interferon mutant and polyethylene glycol derivative thereof |
| 12/22/2010 | CN101921326A Recombinant decorsin mutant, preparation method and application thereof |
| 12/22/2010 | CN101921325A Antigen capable of increasing CD4 + CD25 + Foxp3 + regulatory T cells and application thereof |
| 12/22/2010 | CN101921319A Rubiaceae-type cyclopeptides, medicinal compositions using same as active ingredients, and preparation method and application thereof |
| 12/22/2010 | CN101921314A Brain-targeting neurotrophic factor fusion polypeptide for preventing and treating Alzheimer's disease |
| 12/22/2010 | CN101921313A Polypeptide for curing or preventing cancer or derivative product and application thereof |
| 12/22/2010 | CN101921309A L-cystyl-2-L-aspartic tripeptide and derivatives, preparation method and application thereof |
| 12/22/2010 | CN101921308A Compound with anti-HCV activity and application thereof |
| 12/22/2010 | CN101920007A Composition for preventing and controlling fatty liver disease |
| 12/22/2010 | CN101920006A Cyclin Y and use thereof |
| 12/22/2010 | CN101920005A Novel skin radiation injury protective agent |
| 12/22/2010 | CN101920004A Preparation and application of coconut globulin ferrous complex iron supplement agent |
| 12/22/2010 | CN101919813A Method for preparing chitosan nanoparticles with recombinant human endostar for injection |
| 12/22/2010 | CN101919368A Preparation of hirudinaria manillensis and novel application thereof in Chinese medical science blood stasis |
| 12/22/2010 | CN101647783B Prefreezing method in preparing injection-used reduced glutathione with freeze drying method |
| 12/22/2010 | CN101371925B Nano silver-cell growth factor sustained-release composite body as well as preparation method and use thereof |
| 12/22/2010 | CN101336915B Medicine combination with antitumor activity |
| 12/22/2010 | CN101289507B Collagen protein and collagen polypeptides, preparation thereof and applications |
| 12/22/2010 | CN101270158B Target glioma resistant protein, preparation method and application |
| 12/22/2010 | CN101209342B Application of helianthus tuberosus agglutinin in preparing medicine for treating constipation and delaying stomach and intestine retrogradation |
| 12/22/2010 | CN101191130B ChIFNGR1 gene and its coding protein and application |
| 12/21/2010 | US7855279 Unstructured recombinant polymers and uses thereof |
| 12/21/2010 | US7855278 antibodies which induces the death of a cell that expresses Stra6 polypeptide; used to prevent or slow down (lessen) the development, growth, or spread of tumor characterized by the overexpression of a PRO10282 polypeptide; chemotherapy |
| 12/21/2010 | US7855277 antibody or antiserum directed against a structural protein of Ljungan picornavirus; cardiovascular, nervous system and metabolic disorders; Myocarditis, Cardiomyopathia, Guillain Barre Syndrome, and Diabetes Mellitus, Multiple Sclerosis, Chronic Fatigue Syndrome, Myasthenia Gravis |
| 12/21/2010 | US7855274 Recombinant factor VIII having increased specific activity |
| 12/21/2010 | US7855272 Fibrinogen binding protein for use in diagnosis, prevention and treatment of Staphylococcal infection; bactericides |
| 12/21/2010 | US7855271 Isolated polypeptide comprising amino acid sequence encoded by polynucleotide; physiologically acceptable carriers and immunostimulants |
| 12/21/2010 | US7855269 Down-regulating IL-19 comprising administering to an individual a polypeptide comprised of the extracellular domain of IL-20RA and the extracellular domain of IL-20RB. |
| 12/21/2010 | US7855268 Tolerogizing compositions comprising botulinum toxin type B peptides |
| 12/21/2010 | US7855185 MN gene and protein |
| 12/21/2010 | US7855184 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells and methods of treating ophthalmic and dermatological diseases |
| 12/21/2010 | US7855183 Methods of treatment of a bcl-2 disorder using bcl-2 antisense oligomers |
| 12/21/2010 | US7855182 Using glypican 5 antagonist as therapeutic in treatment of mammary gland cell proliferative disorders |
| 12/21/2010 | US7855181 Dipeptides for prevention of muscle breakdown and microbial infection |
| 12/21/2010 | US7855180 a silicon oxide porous body having gold particles as coverings for the pores and connecting members comprised of variable regions of an antibody, that bind to the gold particles, used for controlled release of drugs at a prescribed site |